<DOC>
	<DOC>NCT01321502</DOC>
	<brief_summary>The objective of this study was to prove the bioequivalence of Famciclovir 500 mg Tablets under fed conditions.</brief_summary>
	<brief_title>Bioequivalency Study of Famciclovir 500 mg Tablets Under Fed Conditions</brief_title>
	<detailed_description />
	<mesh_term>Famciclovir</mesh_term>
	<mesh_term>2-Aminopurine</mesh_term>
	<criteria>No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening Positive test for HIV, Hepatitis B, or Hepatitis C. Treatment with known enzyme altering drugs. History of allergic or adverse response to famciclovir, penciclovir or any comparable or similar product.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>treatment of herpes</keyword>
</DOC>